Middle East Society for Sexual Medicine March 2013 Issue 4
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Successful Uterovaginal Anastomosis in an Unusual Presentation Of
JSAFOMS Successful Uterovaginal Anastomosis in an Unusual Presentation10.5005/jp-journals-10032-1056 of Congenital Absence of Cervix CASE REPORT Successful Uterovaginal Anastomosis in an Unusual Presentation of Congenital Absence of Cervix 1Nusrat Mahmud, 2Naushaba Tarannum Mahtab, 3TA Chowdhury, 4Anjan Kumar Deb ABSTRACT Source of support: Nil Cervical agenesis or dysgenesis (fragmentation, fibrous cord Conflict of interest: None and obstruction) is an extremely rare congenital anomaly. Conser vative surgical approach to these patients involves uterovaginal anastomosis, cervical canalization and cervical INTRODUCTION reconstruction. In failed conservative surgery, total hysterec- Primary amenorrhea is defined as absence of menstrua- tomy is the treatment of choice. We report what we believe to be the first successful end-to-end uterovaginal anastomosis of tion by the age of 14 years in the absence of secondary an unusual case of congenital cervical agenesis. A 25-year- sex characteristics or the absence of periods by the age of old female presented complaining of primary amenorrhea 16 years regardless of appearance of secondary sex and primary subfertility for the same duration. At laparoscopy, complete separation between the cervix and the body of the charac ters. In our last study, a series of total 108 cases uterus was found and hanging from surrounding supports. of primary amenorrhea were reviewed. It was found Both ovaries and fallopian tubes were anatomically positioned. that 69.4% were due Müllerian dysgenesis, 19.4% due to There was another muscular tissue of 2 cm in diameter at the gonadal dysgenesis, 2.7% male pseudohermaphroditism pouch of Douglas which was attached with lateral pelvic wall 13 by transverse cervical ligament. -
GERONTOLOGICAL NURSE PRACTITIONER Review and Resource M Anual
13 Male Reproductive System Disorders Vaunette Fay, PhD, RN, FNP-BC, GNP-BC GERIATRIC APPRoACH Normal Changes of Aging Male Reproductive System • Decreased testosterone level leads to increased estrogen-to-androgen ratio • Testicular atrophy • Decreased sperm motility; fertility reduced but extant • Increased incidence of gynecomastia Sexual function • Slowed arousal—increased time to achieve erection • Erection less firm, shorter lasting • Delayed ejaculation and decreased forcefulness at ejaculation • Longer interval to achieving subsequent erection Prostate • By fourth decade of life, stromal fibrous elements and glandular tissue hypertrophy, stimulated by dihydrotestosterone (DHT, the active androgen within the prostate); hyperplastic nodules enlarge in size, ultimately leading to urethral obstruction 398 GERONTOLOGICAL NURSE PRACTITIONER Review and Resource M anual Clinical Implications History • Many men are overly sensitive about complaints of the male genitourinary system; men are often not inclined to initiate discussion, seek help; important to take active role in screening with an approach that is open, trustworthy, and nonjudgmental • Sexual function remains important to many men, even at ages over 80 • Lack of an available partner, poor health, erectile dysfunction, medication adverse effects, and lack of desire are the main reasons men do not continue to have sex • Acute and chronic alcohol use can lead to impotence in men • Nocturia is reported in 66% of patients over 65 – Due to impaired ability to concentrate urine, reduced -
Septate Uterus As Congenital Uterine Anomaly: a Case Report
em & yst Se S xu e a v l i t D c i s u o Reproductive System & Sexual Moghadam et al., Reprod Syst Sex Disord 2014, 3:4 d r o d r e p r e DOI: 10.4172/2161-038X.1000141 s R ISSN: 2161-038X Disorders: Current Research Case Report Open Access Septate Uterus as Congenital Uterine Anomaly: A Case Report Abas Heidari Moghadam1,2, Zahra Jozi1, Shapoor Dahaz1 and DarioushBijan Nejad1* 1Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences (AJUMS), Ahvaz, Iran 2Diagnostic Imaging Center of Ahvaz Oil Grand Hospital, Ahvaz, Iran *Correspondingauthor: Darioush Bijan Nejad, Assistant Professor, Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences (AJUMS), Ahvaz, Iran, Tel: +98 918 343 4253; Fax: +98 611 333 6380; E-mail:[email protected] Received: June 14, 2014; Accepted: August 01, 2014; Published: August 08, 2014 Copyright: © 2013 Moghadam AH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Abnormal fusion of Mullerian duct in embryonic life is the origin of variety of malformations which may alter the reproductive outcome of the patients. Septate uterus is caused by incomplete resorption of the Mullerian duct during embryogenesis. Here, we report a case of septate uterus that was initially diagnosed by ultrasound scan and confirmed by Magnetic Resonance Imaging (MRI) technique. Keywords: Septate uterus; Mullarian ducts; Ultrasound; MRI Case Report A 29 year old lady came to the imaging diagnostic center of Ahvaz Introduction Oil Grand Hospital. -
Management of Male Lower Urinary Tract Symptoms (LUTS), Incl
Guidelines on the Management of Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) M. Oelke (chair), A. Bachmann, A. Descazeaud, M. Emberton, S. Gravas, M.C. Michel, J. N’Dow, J. Nordling, J.J. de la Rosette © European Association of Urology 2013 TABLE OF CONTENTS PAGE 1. INTRODUCTION 6 1.1 References 7 2. ASSESSMENT 8 3. CONSERVATIVE TREATMENT 9 3.1 Watchful waiting - behavioural treatment 9 3.2 Patient selection 9 3.3 Education, reassurance, and periodic monitoring 9 3.4 Lifestyle advice 10 3.5 Practical considerations 10 3.6 Recommendations 10 3.7 References 10 4. DRUG TREATMENT 11 4.1 a1-adrenoceptor antagonists (a1-blockers) 11 4.1.1 Mechanism of action 11 4.1.2 Available drugs 11 4.1.3 Efficacy 12 4.1.4 Tolerability and safety 13 4.1.5 Practical considerations 14 4.1.6 Recommendation 14 4.1.7 References 14 4.2 5a-reductase inhibitors 15 4.2.1 Mechanism of action 15 4.2.2 Available drugs 16 4.2.3 Efficacy 16 4.2.4 Tolerability and safety 17 4.2.5 Practical considerations 17 4.2.6 Recommendations 18 4.2.7 References 18 4.3 Muscarinic receptor antagonists 19 4.3.1 Mechanism of action 19 4.3.2 Available drugs 20 4.3.3 Efficacy 20 4.3.4 Tolerability and safety 21 4.3.5 Practical considerations 22 4.3.6 Recommendations 22 4.3.7 References 22 4.4 Plant extracts - Phytotherapy 23 4.4.1 Mechanism of action 23 4.4.2 Available drugs 23 4.4.3 Efficacy 24 4.4.4 Tolerability and safety 26 4.4.5 Practical considerations 26 4.4.6 Recommendations 26 4.4.7 References 26 4.5 Vasopressin analogue - desmopressin 27 4.5.1 -
Female Infertility: Ultrasound and Hysterosalpoingography
s z Available online at http://www.journalcra.com INTERNATIONAL JOURNAL OF CURRENT RESEARCH International Journal of Current Research Vol. 11, Issue, 01, pp.745-754, January, 2019 DOI: https://doi.org/10.24941/ijcr.34061.01.2019 ISSN: 0975-833X RESEARCH ARTICLE FEMALE INFERTILITY: ULTRASOUND AND HYSTEROSALPOINGOGRAPHY 1*Dr. Muna Mahmood Daood, 2Dr. Khawla Natheer Hameed Al Tawel and 3 Dr. Noor Al _Huda Abd Jarjees 1Radiologist Specialist, Ibin Al Atheer hospital, Mosul, Iraq 2Lecturer Radiologist Specialist, Institue of radiology, Mosul, Iraq 3Radiologist Specialist, Ibin Al Atheer Hospital, Mosu, Iraq ARTICLE INFO ABSTRACT Article History: The causes of female infertility are multifactorial and necessitate comprehensive evaluation including Received 09th October, 2018 physical examination, hormonal testing, and imaging. Given the associated psychological and Received in revised form th financial stress that imaging can cause, infertility patients benefit from a structured and streamlined 26 November, 2018 evaluation. The goal of such a work up is to evaluate the uterus, endometrium, and fallopian tubes for Accepted 04th December, 2018 anomalies or abnormalities potentially preventing normal conception. Published online 31st January, 2019 Key Words: WHO: World Health Organization, HSG, Hysterosalpingography, US: Ultrasound PID: pelvic Inflammatory Disease, IV: Intravenous. OHSS: Ovarian Hyper Stimulation Syndrome. Copyright © 2019, Muna Mahmood Daood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Dr. Muna Mahmood Daood, Dr. Khawla Natheer Hameed Al Tawel and Dr. Noor Al _Huda Abd Jarjees. 2019. “Female infertility: ultrasound and hysterosalpoingography”, International Journal of Current Research, 11, (01), 745-754. -
Phimosis Table of Contents
Information for Patients English Phimosis Table of contents What is phimosis? ................................................................................................. 3 How common is phimosis? ............................................................................. 3 What causes phimosis? ..................................................................................... 3 Symptoms and Diagnosis ................................................................................. 3 Treatment ................................................................................................................... 4 Topical steroid .......................................................................................................... 4 Circumcision .............................................................................................................. 4 How is circumcision performed? .................................................................. 4 Recovery ...................................................................................................................... 5 Paraphimosis ........................................................................................................... 5 Emergency treatment ....................................................................................... 5 Living with phimosis ........................................................................................... 5 Glossary ................................................................................... 6 This information -
Management of Reproductive Tract Anomalies
The Journal of Obstetrics and Gynecology of India (May–June 2017) 67(3):162–167 DOI 10.1007/s13224-017-1001-8 INVITED MINI REVIEW Management of Reproductive Tract Anomalies 1 1 Garima Kachhawa • Alka Kriplani Received: 29 March 2017 / Accepted: 21 April 2017 / Published online: 2 May 2017 Ó Federation of Obstetric & Gynecological Societies of India 2017 About the Author Dr. Garima Kachhawa is a consultant Obstetrician and Gynaecologist in Delhi since over 15 years; at present, she is working as faculty at the premiere institute of India, prestigious All India Institute of Medical Sciences, New Delhi. She has several publications in various national and international journals to her credit. She has been awarded various national awards, including Dr. Siuli Rudra Sinha Prize by FOGSI and AV Gandhi award for best research in endocrinology. Her field of interest is endoscopy and reproductive and adolescent endocrinology. She has served as the Joint Secretary of FOGSI in 2016–2017. Abstract Reproductive tract malformations are rare in problems depend on the anatomic distortions, which may general population but are commonly encountered in range from congenital absence of the vagina to complex women with infertility and recurrent pregnancy loss. defects in the lateral and vertical fusion of the Mu¨llerian Obstructive anomalies present around menarche causing duct system. Identification of symptoms and timely diag- extreme pain and adversely affecting the life of the young nosis are an important key to the management of these women. The clinical signs, symptoms and reproductive defects. Although MRI being gold standard in delineating uterine anatomy, recent advances in imaging technology, specifically 3-dimensional ultrasound, achieve accurate Dr. -
Midwifery & Women's Health Nurse Practitioner Certification Review
MIDWIFERY & WOMEN’S HEALTH NURSE PRACTITIONER CERTIFICATION REVIEW GUIDE Second Edition Edited by Beth M. Kelsey, EdD, WHNP-BC Assistant Professor School of Nursing Ball State University Muncie, Indiana Board of Directors National Association of Nurse Practitioners in Women’s Health (NPWH) Washington, DC 74172_FMXx_ttlpg.indd 1 7/30/10 2:53 PM World Headquarters Jones & Bartlett Learning Jones & Bartlett Learning Jones and Bartlett Learning 40 Tall Pine Drive Canada International Sudbury, MA 01776 6339 Ormindale Way Barb House, Barb Mews 978-443-5000 Mississauga, Ontario L5V 1J2 London W6 7PA [email protected] Canada United Kingdom www.jblearning.com Jones & Bartlett Learning books and products are available through most bookstores and online booksellers. To contact Jones & Bartlett Learning directly, call 800-832-0034, fax 978-443-8000, or visit our website, www.jblearning.com. Substantial discounts on bulk quantities of Jones & Bartlett Learning publications are available to corporations, professional associations, and other qualified organizations. For details and specific discount information, contact the special sales department at Jones & Bartlett Learning via the above contact information or send an email to [email protected]. Copyright © 2011 by Jones & Bartlett Learning, LLC All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission from the copyright owner. The authors, editor, and publisher have made every effort to provide accurate information. However, they are not responsible for errors, omissions, or for any outcomes related to the use of the contents of this book and take no responsibility for the use of the products and procedures described. -
EAU-Guidelines-On-Paediatric-Urology-2019.Pdf
EAU Guidelines on Paediatric Urology C. Radmayr (Chair), G. Bogaert, H.S. Dogan, R. Kocvara˘ , J.M. Nijman (Vice-chair), R. Stein, S. Tekgül Guidelines Associates: L.A. ‘t Hoen, J. Quaedackers, M.S. Silay, S. Undre European Society for Paediatric Urology © European Association of Urology 2019 TABLE OF CONTENTS PAGE 1. INTRODUCTION 8 1.1 Aim 8 1.2 Panel composition 8 1.3 Available publications 8 1.4 Publication history 8 1.5 Summary of changes 8 1.5.1 New and changed recommendations 9 2. METHODS 9 2.1 Introduction 9 2.2 Peer review 9 2.3 Future goals 9 3. THE GUIDELINE 10 3.1 Phimosis 10 3.1.1 Epidemiology, aetiology and pathophysiology 10 3.1.2 Classification systems 10 3.1.3 Diagnostic evaluation 10 3.1.4 Management 10 3.1.5 Follow-up 11 3.1.6 Summary of evidence and recommendations for the management of phimosis 11 3.2 Management of undescended testes 11 3.2.1 Background 11 3.2.2 Classification 11 3.2.2.1 Palpable testes 12 3.2.2.2 Non-palpable testes 12 3.2.3 Diagnostic evaluation 13 3.2.3.1 History 13 3.2.3.2 Physical examination 13 3.2.3.3 Imaging studies 13 3.2.4 Management 13 3.2.4.1 Medical therapy 13 3.2.4.1.1 Medical therapy for testicular descent 13 3.2.4.1.2 Medical therapy for fertility potential 14 3.2.4.2 Surgical therapy 14 3.2.4.2.1 Palpable testes 14 3.2.4.2.1.1 Inguinal orchidopexy 14 3.2.4.2.1.2 Scrotal orchidopexy 15 3.2.4.2.2 Non-palpable testes 15 3.2.4.2.3 Complications of surgical therapy 15 3.2.4.2.4 Surgical therapy for undescended testes after puberty 15 3.2.5 Undescended testes and fertility 16 3.2.6 Undescended -
Medical and Nursing Specialists, Physicians, and Physician Assistants Handbook
MEDICAL AND NURSING SPECIALISTS, PHYSICIANS, AND PHYSICIAN ASSISTANTS HANDBOOK TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 2 JUNE 2021 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 2 JUNE 2021 MEDICAL AND NURSING SPECIALISTS, PHYSICIANS, AND PHYSICIAN ASSISTANTS Table of Contents 1 General Information . 12 1.1 Payment Window Reimbursement Guidelines for Services Preceding an Inpatient Admission. .12 2 Chiropractic Manipulative Treatment (CMT) . .13 2.1 Enrollment . .13 2.2 Services, Benefits, Limitations, and Prior Authorization. .13 2.2.1 Prior Authorization . 14 2.3 Documentation Requirements . .14 2.4 Claims Filing and Reimbursement . .14 2.4.1 Claims Information . 14 2.4.2 Reimbursement . 14 3 Certified Nurse Midwife (CNM) . .15 3.1 Provider Enrollment. .15 3.1.1 Enrollment in Texas Health Steps (THSteps) . 16 3.2 Services, Benefits, Limitations, and Prior Authorization. .16 3.2.1 Deliveries . 16 3.2.2 Newborn Services . 16 3.2.3 Prenatal and Postpartum Services. 16 3.2.4 Laboratory and Radiology Services . 16 3.2.5 Prior Authorization . 16 3.2.6 Documentation Requirements . 17 3.2.7 Claims Filing and Reimbursement. 17 4 Certified Registered Nurse Anesthetist (CRNA) . .18 4.1 Enrollment . .18 4.2 Services, Benefits, Limitations, and Prior Authorization. .18 4.2.1 Prior Authorization . 19 4.3 Documentation Requirements . .19 4.4 Claims Filing and Reimbursement . .19 4.4.1 Claims Information . 19 4.4.1.1 Interpreting the R&S Report. 19 4.4.2 Reimbursement . 19 5 Geneticists . .20 5.1 Enrollment . .20 5.1.1 Geneticists . 20 5.2 Services, Benefits, Limitations, and Prior Authorization. .21 5.2.1 Family History . -
Risk Factors for Squamous Cell Carcinoma of the Penis— Population-Based Case-Control Study in Denmark
2683 Risk Factors for Squamous Cell Carcinoma of the Penis— Population-Based Case-Control Study in Denmark Birgitte Schu¨tt Madsen,1 Adriaan J.C. van den Brule,2 Helle Lone Jensen,3 Jan Wohlfahrt,1 and Morten Frisch1 1Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, Copenhagen, Denmark; 2Department of Pathology, VU Medical Center, Amsterdam and Laboratory for Pathology and Medical Microbiology, PAMM Laboratories, Michelangelolaan 2, 5623 EJ Eindhoven, the Netherlands;and 3Department of Pathology, Gentofte University Hospital, Niels Andersens Vej 65, Hellerup, Denmark Abstract Few etiologic studies of squamous cell carcinoma female sex partners, number of female sex partners (SCC) of the penis have been carried out in populations before age 20, age at first intercourse, penile-oral sex, a where childhood circumcision is rare. A total of 71 history of anogenital warts, and never having used patients with invasive (n = 53) or in situ (n = 18) penile condoms. Histories of phimosis and priapism at least 5 SCC, 86 prostate cancer controls, and 103 population years before diagnosis were also significant risk controls were interviewed in a population-based case- factors, whereas alcohol abstinence was associated control study in Denmark. For 37 penile SCC patients, with reduced risk. Our study confirms sexually tissue samples were PCR examined for human papil- transmitted HPV16 infection and phimosis as major lomavirus (HPV) DNA. Overall, 65% of PCR-examined risk factors for penile SCC and suggests that penile- penile SCCs were high-risk HPV-positive, most of oral sex may be an important means of viral transmis- which (22 of 24; 92%) were due to HPV16. -
6Th I-DSD Symposium Programme. 29Th June – 1St July 2017, Copenhagen, Denmark
6th I-DSD Symposium Programme. 29th June – 1st July 2017, Copenhagen, Denmark Abstracts Session 1 – Setting The Scene “Stuck in the middle” Eric Vilain MD PhD For families, the birth of a child with a Disorder/Difference of Sex Development (DSD), and uncertainty about the child’s gender and future psychosocial development, is believed to be very stressful. Potential stressors include the parents’ need to gather medical information, make decisions about gender assignment and surgical interventions, cope with medical treatments and the possibility of multiple operations, and handle familial strains related to the perceived stigma of DSD. These stressors are amplified by a large number of uncertainties in the management of DSD. I will review the current uncertainties in the world of DSD (naming, diagnosis, gender, genital surgery, disclosure, fertility, outcomes) and discuss how I have attempted to navigate the waters –often troubled- flowing between the different stakeholders involved with DSD. Session 2 – International Collaborations & Moving Forward The needs of people with conditions affecting sex development Joanne Hall (CLIMB CAH Group) Joanne is a mother of two daughters with salt wasting Congenital Adrenal Hyperplasia and is a member of the UK based CAH support group. Joanne represents the support group at European COST Action meetings and through this recently co-ordinated a European based patient/parent workshop, primarily to engage with professionals and discuss what has worked and has not worked with patient care from childhood through to adulthood. Using learning from this workshop, along with her personal and professional experience of working with families and facilitating groups, Joanne hopes to provide information and practical guidance for professionals to engage with parents and patients, in order to find out what the needs are for people affected by conditions of sexual development within the professional’s own local clinical setting.